Vincenzo L'Imperio

Has grant

Assistant Professor

Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca
Country flagItaly

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vincenzo L'Imperio is an Assistant Professor at the Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca in Italy. His research focuses on machine learning applications in medical diagnostics, particularly in the classification of thyroid nodules and the enhancement of digital pathology workflows. Recent publications include studies on proteomics, spatially resolved molecular characterization, and digital counting technologies for molecular analysis.

Recent Grants

Grant: Close

GR-2021-12374235 “A Digital Pathology Platform for Molecular Onconephrology: the PROFOUND project”

Open Date: 2023-04-01

Close Date: 2026-04-01

Grant: Open

PNC0000003 "ANTHEM: AdvaNced Technologies for HumancentrEd Medicine"

Open Date: 2022-12-01

Close Date: 2026-11-01

Articles (24)

Year:

2025

Year:

2025

Year:

2025

In the molecular era, proper archival conditions within pathology laboratories are crucial, especially for formalin-fixed paraffin-embedded (FFPE) tissue specimens retrieved years after the original diagnosis. Indeed, improper preservation can impact the integrity of nucleic acids and protein antigens. This study evaluates the quality status of stored FFPE blocks using multilevel omics approaches. FFPE blocks from 45 Non-Small Cell Lung Carcinoma (NSCLC) cases were analyzed. The blocks were collected from six different pathology archives across Italy with distinct environmental characteristics. Nucleic acids’ quantity and quality, as well as protein antigens, were assessed using various techniques, including MALDI-MSI. RNA was quantitatively higher, but more fragmented, compared to DNA. DNA quantity and quality were suitable for molecular analyses in 94.4% and 62.3% of samples, respectively. RNA quantity was adequate across all samples, but it was optimal only in 22.3% of cases. DNA quality started to deteriorate after 6–8 years, whereas RNA quality diminished only after 10 years of storage. These data might suggest a particular DNA susceptibility to FFPE blocks conservation. Immunohistochemical intensity decreased significantly after 6–8 years of storage, and MALDI-MSI analysis revealed that younger tissue blocks contained more unique proteomic signals than the older ones. This study emphasizes the importance of proper FFPE archiving conditions for molecular analyses. Governance should prioritize attention to pathology archives to ensure quality preservation and optimize predictive testing. By elucidating the nuances of FFPE block storage, this research paves the way for enhanced molecular diagnostics and therapeutic insights regarding oncology and beyond.

Year:

2024

Kidney transplantation is the best treatment for end-stage renal disease since it offers the greatest survival benefit compared to dialysis. The gap between the number of renal transplants performed and the number of patients awaiting renal transplants leads to a steadily increasing pressure on the scientific community. Kidney preimplantation biopsy is used as a component of the evaluation of organ quality before acceptance for transplantation. However, the reliability and predictive value of biopsy data are controversial. Most of the previously proposed predictive models were not associated with graft survival, but what has to be reaffirmed is that histologic examination of kidney tissue can provide an objective window on the state of the organ that cannot be deduced from clinical records and renal functional studies. The balance of evidence indicates that reliable decisions about donor suitability must be made based on the overall picture. This work discusses recent trends that can reduce diagnostic timing and variability among players in the decision-making process that lead to kidney transplants, from the pathologist’s perspective.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (17)

Fulvio Magni

Full Professor in Biochemistry

University of Milano-Bicocca

ITALY
View details

Claudio Bellevicine

-

ITALY
View details

Isabella Piga

University of Milano-Bicocca

ITALY
View details

Stefano Marletta

University of Verona

ITALY
View details

Alessandro Caputo

-

ITALY
View details

Marco Nobile

Associate Professor

Università Ca' Foscari

ITALY
View details

Giovanni Gambaro

Full Professor/Director

University of Verona

ITALY
View details

Mariia Ivanova

University of Milan

ITALY
View details

Fabio Pagni

University of Milano-Bicocca

ITALY
View details

Stefano Gobbo

Professore Associato

University of Ferrara

ITALY
View details

Albino Eccher

-

ITALY
View details

Maurizio Martini

University of Messina

ITALY
View details

Aldo Scarpa

Professor of Pathology

University of Verona

ITALY
View details

Kurt Zatloukal

Medical University of Graz

AUSTRIA
View details

Heimo Müller

Medical University of Graz

AUSTRIA
View details

Vincenzo Fiorentino

-

ITALY
View details

ANDREA GIANATTI

Chief of Department

-

ITALY
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.